Efficacy and safety of interferon alpha therapy in children with chronic hepatitis B: A long-term follow-up cohort study from China

Interferon-alpha (IFN-α) is currently the preferred antiviral treatment for children with chronic hepatitis B (CHB) aged >1-year-old. However, the evidence regarding the exact efficacy and safety in the real world is not sufficient. This study aimed to investigate the efficacy of IFN-α therapy in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yao, Ye, Yingzi, Ye, Lijing, Wang, Xiaohong, Yu, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708814/
https://www.ncbi.nlm.nih.gov/pubmed/31393369
http://dx.doi.org/10.1097/MD.0000000000016683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708814/
https://www.ncbi.nlm.nih.gov/pubmed/31393369
http://dx.doi.org/10.1097/MD.0000000000016683

Ejemplares similares